Registry study for adults after retroperitoneal sarcoma surgery
Part of Cancer clinical trials.
This study follows adults who have had surgery for a retroperitoneal sarcoma. It collects clinical and imaging information after treatment to better understand outcomes and guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- You had your first surgery for a retroperitoneal sarcoma at the study center
- Your diagnosis was confirmed from a biopsy or surgical tissue sample by a sarcoma specialist
- You had imaging (CT with contrast and/or MRI) before the surgery
- You can sign consent and are willing to return for follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with rare abdominal sarcomas who also had part of their colon removed during surgery. It aims to understand how these combined surgeries affect outcomes, helping doctors better care for future patients.
This study tests whether a short course of radiation before surgery can treat retroperitoneal sarcoma (a rare cancer in the back of the belly). It is for people whose tumor is removable and who have not had previous radiation in the same area.
This trial tests a new way of giving radiation called proton spatially fractionated radiotherapy (P-SFRT) combined with standard radiation for people with a type of sarcoma in the back of the belly. The goal is to see if this combination can treat the tumor more effectively.
This trial tests giving chemotherapy together with a targeted treatment before surgery for people with a high-risk retroperitoneal sarcoma. The goal is to shrink or control the tumor so surgery can potentially remove it with minimal remaining disease (R0/R1).
This trial studies whether adding chemotherapy before surgery helps people with high-risk retroperitoneal (abdominal-area) leiomyosarcoma or liposarcoma. The goal is to improve outcomes while comparing surgery alone versus surgery plus neoadjuvant chemotherapy.
This trial tests a precision medicine approach by giving targeted therapy before surgery for high-risk soft tissue sarcoma. The goal is to see if matching treatment to your tumor's type can improve outcomes.
Hear when a new Retroperitoneal Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.